October 26, 2026

Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

Lunit and Summit Therapeutics: Research Will Use Lunit’s AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Biology  Seoul, South Korea and Miami, Florida, October 23, 2026 – Lunit Inc....

recent articles

XIFIN ProNet Leverages Diagnostic Information for Connected, Quality, Patient-Centered Care SAN DIEGO-- XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, released a new...

I was able to see a demonstration of this new release at USCAP 2016 the other day and there are many improvements over the prior version.  The application still provides a robust worklist with fast response to cases and metadata associated...

  How to Protect Your Lab from Costly and Time-Consuming Government Investigations and Qui Tam Lawsuits—and What to Do If the Government Does Come Calling     ORDER YOUR CD TODAY!   If you missed the webinar from...

Escalated demand for Flagship’s tissue analysis capabilities are being driven by proven success. Westminster, CO - March 15, 2016 - Flagship’s track record of success has increased the adoption of the company’s technology and the demand...

Visiopharm, the leading provider of quantitative digital pathology software for diagnostics and research, announces the launch of VIS 6.0-- a powerful new version of their software. VIS 6.0 includes many new features plus Engine™ a new...

Accelerating cancer diagnostics by automating the pathology workflow, employing image analysis for prescreening cases and providing access to a cancer information data trust as a reference tool only makes sense if data storage and retrieval...

OR

platinum partners

gold partners

Silver Partners

Media Partners